Ambu A/S
Ambu A/S, together with its subsidiaries, researches, develops, manufactures, markets, and sells medical technology solutions in North America, Europe, and internationally. The company offers endoscopy products, including bronchoscopes, video laryngoscopes, rhinolaryngoscopes, duodenoscopes, gastroscopes, cystoscopes, ureteroscopes, and displaying and processing units; neurology products, such as… Read more
Market Cap & Net Worth: Ambu A/S (AMBBY)
Ambu A/S (PINK:AMBBY) has a market capitalization of $3.96 Billion ($3.96 Billion) as of March 20, 2026. Listed on the PINK stock exchange, this USA-based company holds position #3632 globally and #2363 in its home market, demonstrating a -5.51% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Ambu A/S's stock price $17.06 by its total outstanding shares 232235404 (232.24 Million).
Ambu A/S Market Cap History: 2017 to 2025
Ambu A/S's market capitalization history from 2017 to 2025. Data shows growth from $3.85 Billion to $3.96 Billion (3.75% CAGR).
Ambu A/S Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Ambu A/S's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.67x
Ambu A/S's market cap is 0.67 times its annual revenue
0.67x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
15.47x
Ambu A/S's market cap is 15.47 times its annual earnings
1.92x
Higher than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2017 | $3.85 Billion | $2.35 Billion | $301.00 Million | 1.64x | 12.80x |
| 2018 | $5.53 Billion | $2.61 Billion | $337.00 Million | 2.12x | 16.42x |
| 2019 | $3.88 Billion | $2.82 Billion | $317.00 Million | 1.38x | 12.23x |
| 2020 | $10.03 Billion | $3.57 Billion | $241.00 Million | 2.81x | 41.62x |
| 2021 | $5.75 Billion | $4.01 Billion | $247.00 Million | 1.43x | 23.29x |
| 2022 | $3.01 Billion | $4.44 Billion | $93.00 Million | 0.68x | 32.31x |
| 2023 | $3.55 Billion | $4.78 Billion | $168.00 Million | 0.74x | 21.15x |
| 2024 | $3.63 Billion | $5.39 Billion | $235.00 Million | 0.67x | 15.47x |
Competitor Companies of AMBBY by Market Capitalization
Companies near Ambu A/S in the global market cap rankings as of March 20, 2026.
Key companies related to Ambu A/S by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #83 globally with a market cap of $185.28 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #154 globally with a market cap of $117.78 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #168 globally with a market cap of $111.17 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #186 globally with a market cap of $103.33 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #83 | Abbott Laboratories | NYSE:ABT | $185.28 Billion | $107.19 |
| #154 | Stryker Corporation | NYSE:SYK | $117.78 Billion | $339.76 |
| #168 | Medtronic PLC | NYSE:MDT | $111.17 Billion | $86.87 |
| #186 | Boston Scientific Corp | NYSE:BSX | $103.33 Billion | $69.89 |
Ambu A/S Historical Marketcap From 2017 to 2025
Between 2017 and today, Ambu A/S's market cap moved from $3.85 Billion to $ 3.96 Billion, with a yearly change of 3.75%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $3.96 Billion | +8.98% |
| 2024 | $3.63 Billion | +2.29% |
| 2023 | $3.55 Billion | +18.24% |
| 2022 | $3.01 Billion | -47.76% |
| 2021 | $5.75 Billion | -42.65% |
| 2020 | $10.03 Billion | +158.65% |
| 2019 | $3.88 Billion | -29.90% |
| 2018 | $5.53 Billion | +43.63% |
| 2017 | $3.85 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 20th, 2026 the market cap of Ambu A/S was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $3.96 Billion USD |
| MoneyControl | $3.96 Billion USD |
| MarketWatch | $3.96 Billion USD |
| marketcap.company | $3.96 Billion USD |
| Reuters | $3.96 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.